Global Antihypertensive Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global antihypertensive drugs market size reached US$ 28.7 Billion in 2022. Looking forward, the market is expected to reach US$ 34.9 Billion by 2028, exhibiting a growth rate (CAGR) of 3.31% during 2022-2028. The increasing prevalence of hypertension, rising number of patients suffering from CVDs, and the growing number of clinical studies represent some of the key factors driving the market.

Antihypertensive drugs are utilized to treat hypertension wherein the force of blood against the walls of the arteries becomes high and can increase the risk of heart disease, stroke, and other health problems. They generally comprise diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators. They work by relaxing the blood vessels, reducing the amount of fluid in the blood vessels, and decreasing the amount of hormones that cause blood vessels to constrict. They also slow down the heartbeat, maintain a healthy systolic BP, improve life expectancy, and minimize the risk of premature death. At present, key players are introducing imidazolines, monatepil, and neutral endopeptidase inhibitors to expand their product portfolio.

Antihypertensive Drugs Market Trends

The surging prevalence of hypertension and high BP among individuals represents one of the major factors driving the demand for antihypertensive drugs around the world. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is influencing the market positively. In addition, the increasing number of patients suffering from cardiovascular diseases (CVDs) on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses is favoring the growth of the market. Apart from this, governing agencies of numerous countries are initiating campaigns to spread awareness about the hypertension disorder, its symptoms, diagnosis, and treatment. This, coupled with the rising number of clinical studies and trials to develop new treatments for hypertension, is strengthening the growth of the market. Furthermore, the growing usage of over the counter (OTC) drugs to treat BP-related diseases on account of expanding healthcare costs is creating a positive outlook for the market. Besides this, there is a rise in the number of online retail platforms that offer antihypertensive drugs according to the dosage needed by the consumer. This, along with significant growth in the pharmaceutical and e-commerce industries, is propelling the growth of the market. Additionally, the increasing adoption of health insurance policies that provide financial assistance for hypertension treatment and minimize healthcare expenses is impelling the growth of the market.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on therapeutic class, type and distribution channel.

Therapeutic Class Insights:

• Diuretics
• ACE Inhibitors
• Calcium Channel Blockers
• Beta-adrenergic Blockers
• Vasodilators

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the therapeutic class. This includes diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others. According to the report, calcium channel blockers represented the largest segment.

Type Insights:

• Primary Hypertension
• Secondary Hypertension

A detailed breakup and analysis of the antihypertensive drugs market based on the type has also been provided in the report. This includes primary hypertension and secondary hypertension. According to the report, primary hypertension accounted for the largest market share.

Distribution Channel Insights:

• Retail Pharmacy
• Hospital Pharmacy
• E-Commerce

The report has provided a detailed breakup and analysis of the antihypertensive drugs market based on the distribution channel. This includes retail pharmacy, hospital pharmacy, and e-commerce. According to the report, hospital pharmacy represented the largest segment.

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Latin America
• Brazil
• Mexico
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for antihypertensive drugs. Some of the factors driving the North America antihypertensive drugs market included expansion of online pharmacies, government initiatives, product innovation, etc.

Competitive Landscape

The report has also provided a comprehensive analysis of the competitive landscape in the global antihypertensive drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global antihypertensive drugs market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global antihypertensive drugs market?
• What is the impact of each driver, restraint, and opportunity on the global antihypertensive drugs market?
• What are the key regional markets?
• Which countries represent the most attractive antihypertensive drugs market?
• What is the breakup of the market based on the therapeutic class?
• Which is the most attractive therapeutic class in the antihypertensive drugs market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the antihypertensive drugs market?
• What is the breakup of the market based on the distribution channel?
• Which is the most attractive distribution channel in the antihypertensive drugs market?
• What is the competitive structure of the global antihypertensive drugs market?
• Who are the key players/companies in the global antihypertensive drugs market?